A novel treatment for advanced mesothelioma is safe and effective and may improve the quality of life for patients who have few treatment options, according to new research. Transarterial chemoperfusion treatment for malignant pleural mesothelioma (MPM) comes with minimal side effects and shows promise for extending the lives of patients who have limited or no remaining treatment options.
As reported in Science Daily, Bela Kis, MD, PhD, the principal investigator on the study and an interventional radiologist at the Moffitt Cancer Center in Tampa, Fl stated that “MPM is a devastating cancer of the pleura, the membranes surrounding the lungs, that is very difficult to treat. The typical survival rate of patients with stage 3 and 4 MPM is around 12 months from diagnosis; but with this new treatment, we are hoping we might be able to extend patients’ lives beyond that — giving them more time with friends and family.”
Know Your Legal Options
For more than 35 years, the Philadelphia-based law firm of NASS CANCELLIERE has represented 4,000 workers who have contracted MESOTHELIOMA
and other forms of asbestos-related illness. Our attorneys have tried over 1,000 cases throughout Pennsylvania and New Jersey and we have collected over $500 million for our clients. Learn more on this website or call 215-546-8200 to speak with an attorney.